29377

29377
Busse W, Bleecker E, FitzGerald J, et al. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial. Lancet Respir Med; 2019. 7(1):46–59. DOI: 10.1016/S2213-2600(18)30406-5. http://www.ncbi.nlm.nih.gov/pubmed/30416083.
Einstellungen
29377
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 17.12.2020 | 17:17 Uhr